Inj. Magnesii Sulfurici Polpharma

Magnesium sulfate, the active ingredient in Inj. Magnesii Sulfurici Polpharma, is an electrolyte presented as an injection for intramuscular and intravenous use. It treats magnesium deficiency and related conditions such as eclampsia, pre‑eclampsia, and certain cardiac arrhythmias.

GNH USA supplies Inj. Magnesii Sulfurici Polpharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Magnesium sulfate is used in the management of electrolyte disturbances and obstetric or cardiac conditions where magnesium deficiency or vasodilation is relevant.

- Magnesium deficiency: restores normal serum magnesium concentrations. - Eclampsia: prevents seizures in pregnant women with severe hypertension. - Pre‑eclampsia: reduces progression to eclampsia and associated complications. - Torsades de pointes: stabilises cardiac repolarisation to terminate ventricular tachyarrhythmia. - Cardiac arrhythmias: corrects magnesium‑related rhythm disturbances.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Flushing or warmth at the injection site - Sweating or diaphoresis - Mild hypotension - Nausea or vomiting - Headache - Dizziness

Serious or Rare Side Effects: - Severe hypotension or cardiovascular collapse - Life‑threatening arrhythmias - Respiratory depression - Hypermagnesemia with neuromuscular weakness - Anaphylactic or severe allergic reaction - Tissue necrosis or ulceration at the injection site

Magnesium sulfate requires careful assessment of patient conditions and monitoring during administration.

- Renal impairment: monitor serum magnesium and adjust dose. - Cardiac disease: use cautiously; continuous ECG monitoring recommended. - Pregnancy: evaluate risk‑benefit, especially in obstetric emergencies. - Concomitant neuromuscular blockers: may potentiate muscle relaxation. - Incompatible solutions: avoid mixing with calcium‑containing fluids. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Magnesium sulfate can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Calcium gluconate: may precipitate insoluble salts. - Aminoglycoside antibiotics: increased risk of neuromuscular blockade. - Potassium‑sparing diuretics: heightened chance of hypermagnesemia.

Moderate Interactions (Monitor Closely): - ACE inhibitors: additive hypotensive effect. - Beta‑blockers: possible enhanced cardiovascular depression. - Loop diuretics: may increase renal magnesium loss, requiring monitoring.